This information was published on 2026-04-16T06:50:56 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2637059 (IR 1908159) |
| (220) |
23 Oct 2025
|
| (300) |
US, 25 Apr 2025, 99154994
|
| (500) |
The mark consists of a stylized letter "S" formed by two opposing, curved elements. Together the elements form a representation of the letter "S" in black and white.
|
| (511) (510) |
Class 10
Intraocular implants, namely, intraocular lenses and lens stability rings, drug delivery devices for use in conjunction with intraocular lenses and lens stability rings; intraocular implants and/or drug delivery devices for use in conjunction with intraocular implants. Class 42 Providing scientific information and analysis in the field of ophthalmic-related health conditions and treatment, reducing onset of, and/or prevention thereof; providing medical and scientific research information in the field of ophthalmic-related health conditions and treatment, reducing onset of, and/or prevention thereof; product and technology development for the treatment, reducing onset of, and/or prevention of ophthalmic-related health conditions. Class 44 Providing medical and scientific information and analysis in the field of ophthalmic-related health conditions and treatment, reducing onset of, and/or prevention thereof; providing medical and scientific research information in the field of ophthalmic-related health conditions and treatment, reducing onset of, and/or prevention thereof. |
| (540) |
|
| (550) | Figurative |
| (730) |
SpyGlass Pharma, Inc.
|
Find out more about publications on the About page.